MORE►
American Cancer Society
Early-stage oncology companies will have the opportunity to compete for lab and office space at BioLabs Pegasus Park, a $25,000 cash prize, and invaluable guidance from industry professionals. [Photo: BioLabs at Pegasus Park]
American Cancer Society’s BrightEdge Golden Ticket Pitch Competition to Be Held at Pegasus Park
by Lance Murray | Oct 24, 2024
Oncology companies seeking seed-stage through Series A funding are invited to apply to the Golden Ticket Pitch Competition, which will be held on March 11, 2025.
by Lance Murray |
Nov 6, 2023
The gift, the largest to date for BrightEdge, will fund a "first-of-its-kind program" called the ACS BrightEdge Texas Accelerator. The two-year pilot innovation program will invest in cutting-edge companies making headway in the fight to eliminate cancer.
MORE►
by David Seeley |
Jul 25, 2023
Awarded to 101 community-based organizations across the state—including many in North Texas—the Blue Impact grants focus on health care access and target impacts of socio-economic and social determinants of health.
MORE►
by Lance Murray |
Jul 13, 2023
Founded in Dallas in 1948 by Al and Virginia Meadows, the foundation has supported programs across Texas, leaving a lasting legacy in all 254 counties. The foundation has provided $1.36 billion through more than 10,000 grants to 3,700 different organizations and groups throughout the state.
MORE►
[Image: Myvector/iStockphoto]
Dallas’ MedCognetics Gets FDA Clearance for Its AI-Enabled Breast Cancer Screening Software
by David Seeley | Dec 20, 2022
The early-stage startup's QmTRIAGE software platform uses AI and machine learning to detect early breast cancers with a "high rate" of accuracy, MedCognetics says. The company has worked with UT Southwestern and UT Dallas to ensure its AI improves outcomes for "all ethnicities," at a time when racial disparities in AI have become a growing concern.
MORE►
